Gene · 9966
Papers2,280
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
21 to 40 of 2,280
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| TL1A and DR3 in IBD: from mucosal immunopathology to a new era of targeted therapy. | Inflamm Bowel Dis | 2026 | 42308012 | PubTator, text mining | PubMed |
| A phase 1 study to evaluate the safety, tolerability, pharmacokinetics and pharmacodynamics of PF-07261271 in healthy participants. | Br J Clin Pharmacol | 2026 | 42235928 | PubTator, text mining | PubMed |
| TL1A as a therapeutic renaissance in inflammatory bowel disease: a systematic review from molecular mechanisms to clinical translation. | J Crohns Colitis | 2026 | 42166713 | PubTator, text mining | PubMed |
| Humoral contributions to checkpoint blockade therapy. | J Immunother Cancer | 2026 | 42114949 | PubTator, text mining | PubMed |
Discovery, development, and characterization of SPY002 and SPY072, two novel extended half-life monoclonal antibodies targeting TL1A: in vitro properties, in vivo pharmacology, pharmacokinetics, and preclinical safety. | MAbs | 2026 | 42106953 | PubTator, text mining | PubMed |
| Unravelling the TL1A-DR3 axis in Hidradenitis suppurativa. | Front Immunol | 2026 | 42099612 | PubTator, text mining | PubMed |
| A high throughput assay to identify modulators of Death Receptor 3 (DR3). | SLAS Discov | 2026 | 42097330 | PubTator, text mining | PubMed |
| Computational nanobody design using graph neural networks and Metropolis Monte Carlo sampling. | Brief Bioinform | 2026 | 42015415 | PubTator, text mining | PubMed |
| Integrative Single-Cell and Machine Learning Analysis Identifies an EMT-Associated Prognostic Signature for Papillary Thyroid Cancer. | Cancer Med | 2026 | 41957879 | PubTator, text mining | PubMed |
| Review Article: TL1A Inhibitors in IBD - Mechanistic Rationale and Clinical Evidence. | Aliment Pharmacol Ther | 2026 | 41941212 | PubTator, text mining | PubMed |
| Analysis of the use of monoclonal antibodies in the treatment of Crohn's disease. | Antib Ther | 2026 | 41930211 | PubTator, text mining | PubMed |
| Therapeutic Potential of Tulisokibart and Anti-TL1A Therapy in Inflammatory Disorders: Current Insights and Future Directions. | Clin Rev Allergy Immunol | 2026 | 41904333 | PubTator, text mining | PubMed |
| Cell-Cell Interactome-Based Pathogenesis and Therapies for Osteosarcoma. | Cells | 2026 | 41892359 | PubTator, text mining | PubMed |
| The Therapeutic Potential of Targeting TL1A in a Spectrum of Inflammatory Disorders. | J Inflamm Res | 2026 | 41867469 | PubTator, text mining | PubMed |
| Differences in the expression profiles of m6A-related genes and the prognostic role in immunotherapy for lung adenocarcinoma patients. | Front Oncol | 2026 | 41809822 | PubTator, text mining | PubMed |
| Identification of core genes mediating the association between obesity and hepatocellular carcinoma: A bioinformatics study based on mitochondrial metabolism and immune pathways. | PLoS One | 2026 | 41801960 | PubTator, text mining | PubMed |
| Treatment of pulmonary fibrosis: From disease mechanisms to future novel therapies (Review). | Int J Mol Med | 2026 | 41789674 | PubTator, text mining | PubMed |
| Crohn's Disease in Malaysia: Could Application of the Precautionary Principle Reduce Future Incidence? | Microorganisms | 2026 | 41753582 | PubTator, text mining | PubMed |
| From Inflammation to Thrombosis: The Prothrombotic State and Cardiovascular Risk in Inflammatory Bowel Disease. | Medicina (Kaunas) | 2026 | 41752670 | PubTator, text mining | PubMed |
| Therapeutic Insights and Immune Pathway Connections Revealed by Core Symptom Gene Network Analysis in Ankylosing Spondylitis. | Curr Issues Mol Biol | 2026 | 41751461 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/9966/papers?page=2